Global Radiodermatitis Market Size, Share, Forecast Report, 2020-2027

The global Radiodermatitis market garnered revenue around USD 334.4 Million in 2019 and projected to reach USD 505.4 Million in 2027, with at a compound annual growth rate (CAGR) 3.4% throughout the estimate period from 2020 to 2027.

Radiodermatitis, alternatively known as radiation dermatitis, is a condition caused by radiation therapy utilized for cancer treatment.

Cumulative daily doses of radiation to the treatment field or target site on the body inhibits the normal skin repopulation and weakens the skin integrity at and around the radiation field Radiodermatitis may be acute or chronic and encompasses localized erythema, skin shedding (desquamation), hair loss (epilation), fibrosis, necrosis, and other similar conditions Radiodermititis may be treated with the following Topical agents - Corticosteroids, hydrophilic creams, topical antibiotics, Oral Medication: Oral corticosteroids, oral analgesics, anti-inflammatory agents, and antibiotics, Dressings: Hydrogel, hydrocolloid, no sting barrier film, honey impregnated gauze, silicone coated dressing, and others (silver dressings and GM-CSF gauze, etc.)

Asia Pacific dominated the global Radiodermatitis Market in 2019 and the trend is anticipated to continue during the forecast period  as this region has a significant pool of patients suffering from cancer as well as taking radiation therapy. Moreover, the basic preventive skincare practices such as washing skin with gentle soap and wearing loose clothing tend to be overlooked by the population in emerging countries. This further increases the need for radiation dermatitis care products.

This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.

The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the Radiodermatitis market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the Radiodermatitis market growth.

The global Radiodermatitis market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.

Major manufacturers analysed under this study comprises:

the global market include 3M & Co., Acelity, BMG Pharma S.r.l., ConvaTec, DermaSciences Inc., Intermed Pharmaceuticals, Molnlycke Health Care, Smith & Nephew plc, Stratpharma AG among others

This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:

Global Radiodermatitis Market, by Product

• Topical
  • Corticosteroids
  • Hydrophilic Creams
  • Others (topical antibiotics)
• Oral Medication
  • Corticosteroids
  • Other (oral analgesics, antibiotics, etc.) 
• Dressings
  • Hydrogel
  • Hydrocolloid
  • No Sting Barrier Film
  • Honey Impregnated Gauze
  • Silicone Coated Dressing
  • Others (GM-CSF gauze, silver leaf dressing, etc.)

Global Radiodermatitis Market, by Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy Store
• Online Store

Regional Analysis and Forecast

Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:

• North America
  • United States
  • Canada
• Europe
  • Germany
  • United Kingdom
  • Italy
  • France
  • Rest of EU
• Asia Pacific
  • China
  • India
  • Japan
  • Southeast Asia
  • Rest of APAC
• Central & South America
  • Brazil
  • Argentina
  • Rest of Central & South America
• Middle East and Africa
  • UAE
  • Saudi Arabia
  • Rest of MEA